Trademark: 98095871
Word
IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)
Status Date
Friday, March 29, 2024
Filing Date
Friday, July 21, 2023
5 Biotechnological preparations for medical use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
1 Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical substances for use in the biotechnological industry; Media for cell culture for use in the biotechnological industry; Chemical reagents for use in biotechnology, other than for medical or veterinary use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
42 Biotechnological research; Biotechnology research; Research relating to biotechnology; Biotechnological research relating to industry; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Information on the subject of scientific research in the field of biochemistry and biotechnology; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer
Mar 29, 2024
Notification Of Non-Final Action E-Mailed
Mar 29, 2024
Non-Final Action E-Mailed
Mar 29, 2024
Non-Final Action Written
Mar 26, 2024
Assigned To Examiner
Jan 28, 2024
Preliminary/Voluntary Amendment - Entered
Jan 25, 2024
Assigned To Lie
Sep 6, 2023
Teas Voluntary Amendment Received
Aug 21, 2023
New Application Office Supplied Data Entered
Jul 25, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
